Immix Biopharma Inc. (IMMX)

1.74

0.03 (1.75%)

At close: Apr 24, 2025, 3:59 PM

1.79

2.83%

After-hours: Apr 24, 2025, 07:43 PM EDT

Immix Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-21.7M	-15.6M	-8.23M	-24.38M	-1.15M	-972.81K
Depreciation & Amortization	115.39K	5.47K	2.13K	2.47K	2.32K	1.08K
Stock-Based Compensation	3.02M	2.57M	624.07K	218.98K	n/a	n/a
Other Working Capital	n/a	-781.56K	-936.53K	-284.97K	169.68K	58.74K
Other Non-Cash Items	3.97M	n/a	100K	118.16K	575K	-84.5K
Deferred Income Tax	n/a	n/a	n/a	22.85M	n/a	n/a
Change in Working Capital	n/a	1.65M	195.21K	-391.04K	165.85K	181.7K
Operating Cash Flow	-14.6M	-11.37M	-7.41M	-1.59M	-404.69K	-790.03K
Capital Expenditures	-1.18M	-52.09K	n/a	-802	n/a	-7.31K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-802	n/a	n/a
Investing Cash Flow	-1.18M	-52.09K	n/a	-802	n/a	-7.31K
Debt Repayment	n/a	n/a	n/a	200K	n/a	1.05M
Common Stock Repurchased	n/a	n/a	-99.96K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.49K	-232K	3.33M	n/a	n/a	n/a
Financial Cash Flow	15.95M	15.46M	3.23M	18.85M	n/a	1.05M
Net Cash Flow	172.17K	4.07M	-4.21M	17.25M	-342.93K	271.69K
Free Cash Flow	-15.77M	-11.42M	-7.41M	-1.59M	-404.69K	-797.34K